ACHV · NASDAQ
Achieve Life Sciences (ACHV) Stock Price & Fundamentals
Achieve Life Sciences (ACHV) closed at $585.44 on Oct 9, 2026, down 1.18% from the previous close of $592.43.
Share price, past year
1Y −4.94%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $585.44 |
| Sep 30, 2026 | $577.93 |
| Aug 31, 2026 | $598.88 |
| Jul 31, 2026 | $634.70 |
| Jun 30, 2026 | $669.42 |
| May 29, 2026 | $636.58 |
| Apr 30, 2026 | $636.50 |
| Mar 31, 2026 | $603.49 |
| Feb 27, 2026 | $623.06 |
| Jan 30, 2026 | $642.02 |
| Dec 31, 2025 | $619.96 |
| Nov 28, 2025 | $610.42 |
| Oct 31, 2025 | $598.56 |
Key statistics
- Market cap
- $60.13B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.50
- Revenue (TTM)
- —
- Net income (TTM)
- −$114.04M
- Shares outstanding
- 102.7M
- Dividend yield
- —
- 52-week range
- $565.87 – $692.41
Achieve Life Sciences's market cap is $60.13B, based on a share price of $585.44 and 102.7M shares outstanding as of Jun 30, 2026.
Financials
Achieve Life Sciences reported revenue of $0.00 for fiscal 2019.
Achieve Life Sciences reported a net loss of $54.65M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2019ended Dec 31, 2019 | $0.00 | — | −$16.40M | — | −$39.76 | −$15.27M |
| FY2018ended Dec 31, 2018 | $0.00 | — | −$12.69M | — | −$72.29 | −$10.67M |
Company profile
- Name
- Achieve Life Sciences, Inc.
- Ticker
- ACHV
- Exchange
- NASDAQ
- Industry (SEC SIC)
- In Vitro & In Vivo Diagnostic Substances
- Headquarters
- 22722 29th Dr. Se, Suite 100, Seattle, WA 98021
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0000949858
Recent SEC filings
- Oct 1, 2026
- Aug 14, 2026
- Aug 11, 2026
- Aug 11, 2026
- Jul 6, 2026
- Jun 2, 2026
- May 12, 2026
- May 12, 2026
Frequently asked questions
What is Achieve Life Sciences's stock price?
Achieve Life Sciences (ACHV) closed at $585.44 on Oct 9, 2026, down 1.18% from the previous close of $592.43.
What is Achieve Life Sciences's market cap?
Achieve Life Sciences's market cap is $60.13B, based on a share price of $585.44 and 102.7M shares outstanding as of Jun 30, 2026.
How much revenue does Achieve Life Sciences make?
Achieve Life Sciences reported revenue of $0.00 for fiscal 2019.
Does Achieve Life Sciences pay a dividend?
Achieve Life Sciences's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Achieve Life Sciences, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures